alexa A Study On The Potential Of Kappa-carrageenan And Carboxymethylcellulose In Extended Release Potassium Chloride Capsules
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Maria Esperanza R Apolinario, Keith Sushmita B Canlas, Jelene Marie R Galang, Gracelyn Mae G Gatus and Bernice O Genson
Accepted Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.013
The drug of choice in preventing and treating hypokalemia is Potassium chloride (KCl). Extending the release of KCl is intended to slow down and prolong the release of potassium in order to reduce the gastrointestinal irritation brought about by KCl. This study aims to discover the feasibility of an extended release KCl capsule formulation using the ideal 1:2 cellulosic ratio of CMC and Kappa-Carrageenan obtained from a previous study, Comparative Study of the Cellulosic Ratio of Carboxymethylcellulose: Kappa-Carrageenan As A Potential Drug Delivery System (Cruz et. al, 2012) by means of compatibility determination, actual formulation of drug product and testing for compliance to monograph specifications for dissolution. The extended release KCl formulation in this study was prepared by means of microencapsulation, oven drying at 85oC and particle size reduction through sieving prior to capsule filling. A sample of the granules from the prepared formulation and the chief ingredients (including CMC, KC and KCl) each underwent Differential Scanning Calorimetry performed by professionals in RCNAS for compatibility determination. The capsules were tested for dissolution by employing the procedures and specifications of USP for extended release KCl capsules. The aliquots were diluted for preparation for AAS to determine the absorbance of the samples necessary for the computation of sample concentration. The data collected were analyzed by using One-Way ANOVA F test and Pearson r correlation. No significant change was seen in the data. It was concluded that the said formulation poorly exhibited extended release property.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version